Glyburide-d3 CAS No.1219803-02-7
 Glyburide-d3 CAS No.1219803-02-7
Glyburide-d3 CAS No.1219803-02-7
						| Catalog # | Pkg Size | Price(USD) | Quantity | Buy this product | 
|---|---|---|---|---|
| R-R-2205 | 2mg | 210.00 | + Add to cart | |
| R-R-2205 | 5mg | 420.00 | + Add to cart | |
|  | ||||
Product description
							Glyburide-d3/CAS No.1219803-02-7 is the deuterium labeled Glibenclamide. Glibenclamide (Glyburide) is an orally active ATP-sensitive K+ channel (KATP) inhibitor and can be used for the research of diabetes and obesity. Glibenclamide inhibits P-glycoprotein. Glibenclamide directly binds and blocks the SUR1 subunits of KATP and inhibits the cystic fibrosis transmembrane conductance regulator protein (CFTR). Glibenclamide interferes with mitochondrial bioenergetics by inducing changes on membrane ion permeability. Glibenclamide can induce autophagy.
 
								| Appearance | N/A | 
|---|---|
| Molecular Weight | 497.02 | 
| Purity | >90% | 
| CAS | 1219803-02-7 | 
| Formula | C23H25D3ClN3O5S | 
| Storage | -20℃, protected from light and moisture | 
| Transportation | 4-25℃ temperature for up to 3 weeks | 
| Stability | 1 year | 
Document
							Related Product
							
						
 Items-$0.00
Items-$0.00

 Email:
Email: Tel.:
Tel.: msds of Glyburide-d3 CAS No.1219803-02-7
msds of Glyburide-d3 CAS No.1219803-02-7  RuixiBiotechCo.Ltd /KamulinBiotechco.ltd
                    RuixiBiotechCo.Ltd /KamulinBiotechco.ltd
                 Add: Room 20F 2002, Meiyuan Building, Yanta District, Xi’ an City, Shaanxi Province 710061 China
                    Add: Room 20F 2002, Meiyuan Building, Yanta District, Xi’ an City, Shaanxi Province 710061 China 
                 Tel:  02988811435
                    Tel:  02988811435
                 Fax: (86-29)8881-1435
                    Fax: (86-29)8881-1435
                 Email: sales@ruixibiotech.com
                    Email: sales@ruixibiotech.com
                 Web: http://www.ruixibiotech.com
                    Web: http://www.ruixibiotech.com    
					
							
                

